Cellyan Biotechnology Co., Ltd (HKPD) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Cellyan Biotechnology Co., Ltd (HKPD) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $5.0M, listed on NASDAQ, employing roughly 27 people, carrying a beta of 2.48 to the broader market. Cellyan Biotechnology Co. Led by Chenyu Liang, public since 2025-01-15.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for HKPD as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →